Your browser doesn't support javascript.
loading
The CD200R1 microglial inhibitory receptor as a therapeutic target in the MPTP model of Parkinson's disease.
Rabaneda-Lombarte, Neus; Serratosa, Joan; Bové, Jordi; Vila, Miquel; Saura, Josep; Solà, Carme.
Affiliation
  • Rabaneda-Lombarte N; Department of Cerebral Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas (CSIC), Institut d'Investigacions Biomèdiques August-Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Serratosa J; Biochemistry and Molecular Biology Unit, School of Medicine, University of Barcelona, IDIBAPS, Barcelona, Spain.
  • Bové J; Department of Cerebral Ischemia and Neurodegeneration, Institut d'Investigacions Biomèdiques de Barcelona-Consejo Superior de Investigaciones Científicas (CSIC), Institut d'Investigacions Biomèdiques August-Pi i Sunyer (IDIBAPS), Barcelona, Spain.
  • Vila M; Vall d'Hebrón Research Institute-CIBERNED, Barcelona, Spain.
  • Saura J; Vall d'Hebrón Research Institute-CIBERNED, Barcelona, Spain.
  • Solà C; Catalan Institution for Research and Advanced Studies (ICREA), Barcelona, Spain.
J Neuroinflammation ; 18(1): 88, 2021 Apr 06.
Article in En | MEDLINE | ID: mdl-33823877

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Microglia / Parkinsonian Disorders / Orexin Receptors Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Neuroinflammation Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Microglia / Parkinsonian Disorders / Orexin Receptors Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Neuroinflammation Journal subject: NEUROLOGIA Year: 2021 Document type: Article Affiliation country: Country of publication: